Clinical Trial Update: Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis [Phase 2]

View source ↗

Summary

Phase 2 trial updating the efficacy and safety of deferasirox in patients with chronic anemia and transfusional hemosiderosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Transfusional Hemosiderosis

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Anemia, Transfusional Hemosiderosis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-29